A pilot clinical trial with molecular marker study of chemosensitization to carboplatin by use of azacitidine in platinum resistant or refractory epithelial ovarian cancer

Trial Profile

A pilot clinical trial with molecular marker study of chemosensitization to carboplatin by use of azacitidine in platinum resistant or refractory epithelial ovarian cancer

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Nov 2009

At a glance

  • Drugs Azacitidine; Carboplatin
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.
    • 24 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top